Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T26851 | ||||
Target Name | Complement C3 (CO3) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Ac-ICV(5fW)QDWGAHRCT-NH2 | Drug Info | IC50 = 1740 nM | [2] | |
Ac-ICV(5MeW)QDWGAHRCT-NH2 | Drug Info | IC50 = 870 nM | [2] | ||
Ac-ICVWQD(5fW)GAHRCT-NH2 | Drug Info | IC50 = 446 nM | [2] | ||
Ac-ICVWQDWGAHRCT-NH2 | Drug Info | IC50 = 1200 nM | [2] | ||
Ac-I[CV(1Nal)QDWGAHRC]T | Drug Info | IC50 = 1800 nM | [1] | ||
Ac-I[CV(2Igl)QDWGAHRC]T | Drug Info | IC50 = 1500 nM | [1] | ||
Ac-I[CV(2Igl)QDWGAHRC]T-NH2 | Drug Info | IC50 = 1400 nM | [1] | ||
Ac-I[CV(2Nal)QDWGAHRC]T | Drug Info | IC50 = 1400 nM | [1] | ||
Ac-I[CV(2Nal)QDWGAHRC]T-NH2 | Drug Info | IC50 = 500 nM | [1] | ||
Ac-I[CV(Bpa)QDWGAHRC]T | Drug Info | IC50 = 1100 nM | [1] | ||
Ac-I[CV(Bpa)QDWGAHRC]T-NH2 | Drug Info | IC50 = 600 nM | [1] | ||
Ac-I[CV(Bta)QDWGAHRC]T | Drug Info | IC50 = 800 nM | [1] | ||
Ac-I[CV(Bta)QDWGAHRC]T-NH2 | Drug Info | IC50 = 800 nM | [1] | ||
Ac-I[CV(Dht)QDWGAHRC]T | Drug Info | IC50 = 10200 nM | [1] | ||
Ac-I[CV(Yphs)QDWGAHRC]I-NH2 | Drug Info | IC50 = 9600 nM | [1] | ||
Ac-I[CVFQDWGHHRC]T-NH2 | Drug Info | IC50 = 6000 nM | [1] | ||
Ac-I[CVHQDWGHHRC]T-NH2 | Drug Info | IC50 = 7000 nM | [1] | ||
Ac-I[CVSQDWGHHRC]T-NH2 | Drug Info | IC50 = 6000 nM | [1] | ||
Ac-I[CVTQDWGHHRC]T-NH2 | Drug Info | IC50 = 6000 nM | [1] | ||
Ac-I[CVVQDWGAHRC]T-NH2 | Drug Info | IC50 = 13000 nM | [1] | ||
Ac-I[CVWQDWG(Abu)HRC]T-NH2 | Drug Info | IC50 = 1500 nM | [1] | ||
Ac-I[CVWQDWGAHRC]dT | Drug Info | IC50 = 2700 nM | [1] | ||
Ac-I[CVWQDWGAHRC]T | Drug Info | IC50 = 12000 nM | [1] | ||
Ac-I[CVWQDWGHHRC]T-NH2 | Drug Info | IC50 = 7000 nM | [1] | ||
Ac-I[CVWQDWGWHRC]T-NH2 | Drug Info | IC50 = 6000 nM | [1] | ||
Ac-I[CVYQDWGAHRC]T-NH2 | Drug Info | IC50 = 3000 nM | [1] | ||
References | |||||
REF 1 | Design and NMR characterization of active analogues of compstatin containing non-natural amino acids. J Med Chem. 2005 Jan 13;48(1):274-86. | ||||
REF 2 | Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem. 2006 Jul 27;49(15):4616-22. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.